Immunologic mechanisms of specific immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 56, 1999, Pages 31-32

  Akdis, C A ^a   Blaser, K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; IMMUNOGLOBULIN G4; INTERLEUKIN 10; PHOSPHOLIPASE A;

ALLERGY; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; IMMUNOREGULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; T-LYMPHOCYTES;

EID: 0032849117     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Akdis CA, Blaser K. IL-10 induced anergy in peripheral T cells and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 1999;13:603-609.
2. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996;98:1676-1683.
3. Akdis CA, Blesken T, Akdis M, et al. The role of IL-10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
4. 2. Int Arch Allergy Immunol 1998;117:1-10.
5. Durham SR, Till SJ. Immunological changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-164.
6. lck and ZAP-70 tyrosine kinase activities. J Immunol 1997;159:53-60.
7. Hoyne GF, O'Hehir R, Wraith DC, et al. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitised mice. J Exp Med 1993;178:1783-1788.
8. 2 induces specific T cell anergy in bee sting allergic patients. J Allergy Clin Immunol 1998;101:747-775.